Picture a scientist employed by a pharmaceutical company publishing research results that were important bricks in a wall of evidence that could massively benefit their employer down the track. Imagine…

As part of pandemic preparation, in the early 2000s many countries amassed large stockpiles of the influenza neuraminidase inhibitor Tamiflu.
Tony Hisgett/Flickr29 septembre 2015